Sahni Sakshi, Watson Randee Miller, Sheth Veeral S
*Chicago Medical School, Rosalind Franklin University, North Chicago, Illinois; †UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, Illinois; and ‡University Retina and Macula Associates, Oak Forest, Illinois.
Retin Cases Brief Rep. 2017;11(3):281-282. doi: 10.1097/ICB.0000000000000345.
To describe a case of acute endophthalmitis caused by Actinomyces neuii after intravitreal anti-vascular endothelial growth factor injection.
Observational case report, review of published literature.
A 67-year-old white man with wet age-related macular degeneration developed endophthalmitis secondary to A. neuii on the 10th day after intravitreal anti-vascular endothelial growth factor injection. Both anterior chamber and vitreous cultures were positive for A. neuii. He was treated successfully with intravitreal injection of vancomycin and ceftazidime.
This is the first published report of culture-positive endophthalmitis caused by A. neuii after intravitreal injection.
描述1例玻璃体内注射抗血管内皮生长因子后由纽氏放线菌引起的急性眼内炎病例。
观察性病例报告，回顾已发表的文献。
1例67岁患有湿性年龄相关性黄斑变性的白人男性，在玻璃体内注射抗血管内皮生长因子后第10天发生了由纽氏放线菌引起的眼内炎。前房和玻璃体培养均显示纽氏放线菌阳性。经玻璃体内注射万古霉素和头孢他啶治疗成功。
这是首次发表的关于玻璃体内注射后由纽氏放线菌引起的培养阳性眼内炎的报告。
